A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor.
Imashuku
S
S
Hibi
S
S
Nakajima
F
F
Mitsui
T
T
Yokoyama
S
S
Kojima
S
S
Matsuyama
T
T
Nakahata
T
T
Ueda
K
K
Tsukimoto
I
I
D000328:Adult; D002648:Child; D002675:Child, Preschool; D002897:Chromosomes, Human, Pair 7; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000209:etiology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009006:Monosomy; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D009503:Neutropenia / Q000188:drug therapy*; D011994:Recombinant Proteins; D012189:Retrospective Studies
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor